These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23835004)

  • 1. Denosumab and atypical femur fractures.
    Cating-Cabral MT; Clarke BL
    Maturitas; 2013 Sep; 76(1):1-2. PubMed ID: 23835004
    [No Abstract]   [Full Text] [Related]  

  • 2. Denosumab and atypical femoral fractures.
    Aspenberg P
    Acta Orthop; 2014 Feb; 85(1):1. PubMed ID: 24171676
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical fracture of the femur in a patient using denosumab--a case report.
    Schilcher J; Aspenberg P
    Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical femoral fractures bilaterally in a patient receiving denosumab.
    Drampalos E; Skarpas G; Barbounakis N; Michos I
    Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
    [No Abstract]   [Full Text] [Related]  

  • 5. To treat osteoporosis, Denosumab appears more effective than Zoledronate. Denosumab has the advantage in building bone density, and has fewer side effects.
    Duke Med Health News; 2014 Mar; 20(3):1-2. PubMed ID: 24683617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report].
    Selvi Sabater P; Rizo Cerdá AM; Titos Arcos JC; Espuny Miró A
    Farm Hosp; 2014 May; 38(3):248-9. PubMed ID: 24951910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral atypical femoral fractures in a patient prescribed denosumab - a case report.
    Thompson RN; Armstrong CL; Heyburn G
    Bone; 2014 Apr; 61():44-7. PubMed ID: 24389366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab is an option for treatment of osteoporosis.
    Simonelli C
    Am Fam Physician; 2012 Dec; 86(11):992; author reply 994. PubMed ID: 23198660
    [No Abstract]   [Full Text] [Related]  

  • 9. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
    Horning JA; Czajka J; Uhl RL
    Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Denosumab--a new efficient osteoporosis therapy].
    Rejnmark L; Vestergaard P; Mosekilde L
    Ugeskr Laeger; 2011 Jan; 173(5):346-9. PubMed ID: 21276398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Femoral Fractures: A Teaching Perspective.
    Khan AA; Leslie WD; Lentle B; Iles S; Kaiser SM; Frame H; Burrell S; Cheung AM
    Can Assoc Radiol J; 2015 May; 66(2):102-7. PubMed ID: 25051904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptomatic hypocalcaemia on denosumab use].
    Baptista Lopes V; Robbrecht D; van Thiel S; van Guldener C
    Ned Tijdschr Geneeskd; 2013; 157(29):A6159. PubMed ID: 23859106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical femoral fractures and their relation to bisphosphonate use.
    Tripto-Shkolnik L
    Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
    [No Abstract]   [Full Text] [Related]  

  • 15. [ASBMR 2010 report. Meeting report on the ASBMR. Obstacles in medicine for osteoporosis].
    Koike T
    Clin Calcium; 2011 Jan; 21(1):104-8. PubMed ID: 21187601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
    Piponov HI; Goldstein JM; Eisenberg GM
    Osteoporos Int; 2020 Nov; 31(11):2263-2267. PubMed ID: 32561954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should we treat thalassemia-induced osteoporosis: two case reports].
    Lucini M; Stoll D; Aubry-Rozier B; Lamy O
    Praxis (Bern 1994); 2012 Oct; 101(20):1325-9. PubMed ID: 23032499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab, osteoporosis, and prevention of fractures.
    Kiechl S; Willeit J; Schett G
    N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
    [No Abstract]   [Full Text] [Related]  

  • 20. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
    Johnson GL
    Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.